Biomarker Research to Support Fertility Regulation Development by Small Business (R43 Clinical Trial Optional)

0
115

Funding Opportunity ID:332895
Opportunity Number:RFA-HD-22-018
Opportunity Title:Biomarker Research to Support Fertility Regulation Development by Small Business (R43 Clinical Trial Optional)
Opportunity Category:Discretionary
Opportunity Category Explanation:
Funding Instrument Type:Grant
Category of Funding Activity:Health
Income Security and Social Services
Category Explanation:
CFDA Number(s):93.865
Eligible Applicants:Small businesses
Additional Information on Eligibility:Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.
Agency Code:HHS-NIH11
Agency Name:Department of Health and Human Services
National Institutes of Health
Posted Date:Apr 15, 2021
Close Date:Jul 29, 2021
Last Updated Date:Apr 15, 2021
Award Ceiling:$259,613
Award Floor:$0
Estimated Total Program Funding:
Expected Number of Awards:
Description:The purpose of this Funding Opportunity Announcement (FOA) is to invite SBIR applications to support and facilitate the development of new and/or improved clinical biomarkers and companion biomarker diagnostics (e.g., point of care and/or direct-to-consumer tests, DTC) to support the clinical development of non-hormonal contraceptive product(s) for men and women.
Version:1





Visit the Official Webpage For More Details on Biomarker Research to Support Fertility Regulation Development by Small Business (R43 Clinical Trial Optional)

LEAVE A REPLY

Please enter your comment!
Please enter your name here